heart failure

Right Heart Catheterization: ATS 2026 Clarifies Waveform Interpretation

ATS 2026 session addresses persistent challenges in right heart catheterization waveform interpretation, offering a structured approach to reduce diagnostic ambiguity.

SGLT2 Inhibitors and Ferroptosis: A New Mechanistic Picture in HF

Emerging evidence links SGLT2 inhibitors' cardiac benefit to ferroptosis suppression, offering a potential mechanistic explanation for their efficacy in heart failure.

SGLT2 Inhibitors Post-Heart Transplant: What the Data Show

A 2026 meta-analysis examines SGLT2 inhibitor use in diabetic heart transplant recipients, a population where evidence has been thin and stakes are high.